Home/Filings/4/0001209191-21-067068
4//SEC Filing

Clements Ian 4

Accession 0001209191-21-067068

CIK 0001759425other

Filed

Nov 28, 7:00 PM ET

Accepted

Nov 29, 9:49 PM ET

Size

6.6 KB

Accession

0001209191-21-067068

Insider Transaction Report

Form 4
Period: 2021-11-24
Clements Ian
SVP Finance & Communications
Transactions
  • Purchase

    Common Stock

    2021-11-24$14.40/sh+700$10,08017,811 total
  • Purchase

    Common Stock

    2021-11-26$13.90/sh+750$10,42518,561 total
Footnotes (1)
  • [F1]The Reporting Person's purchases of MIRM common stock reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of 1,574 shares of MIRM common stock on October 1, 2021 at a price of $19.256. The transactions resulted in short-swing profits of $7,416.20 which the Reporting Person has disgorged to MIRM in accordance with Section 16(b) of the Securities Exchange Act of 1934.

Issuer

Mirum Pharmaceuticals, Inc.

CIK 0001759425

Entity typeother

Related Parties

1
  • filerCIK 0001780080

Filing Metadata

Form type
4
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 9:49 PM ET
Size
6.6 KB